| INTRODUCTION
Living donor (LD) kidney transplantation provides the greatest opportunity to maximize long-term patient and graft survival. [1] [2] [3] [4] Although multiple factors contribute to prolonged graft survival for LDKT recipients, HLA matching remains an important determinant of long-term outcome. [5] [6] [7] [8] First-degree genetic relatives (ie, siblings, parents, offspring), therefore, represent a prevalent and accessible pool of wellmatched kidneys 1, 9 that may optimize long-term allograft outcomes.
Among these donor types, offspring ostensibly represent the ideal donor group given the combined benefit of haplotype matching and younger donor age.
Although most LDKT recipients would benefit from transplantation with offspring donor kidneys, women with a history of pregnancy may be poorly served by this approach. Given that pregnancy is an immune-sensitizing event, long-lived immune memory cells with specificity for offspring HLA may increase the risk of acute or chronic rejection and negate long-term benefit. While the use of offspring donors for female candidates was limited in the past by fears surrounding the potential harm posed by pregnancy-induced memory T and B cells, 10 offspring living donors (LDs) have been associated with excellent
While offspring-to-parent living donor kidney transplantations may represent an ideal donor-recipient combination to optimize long-term transplantation outcomes, the sex-specific long-term success of these transplantations remains unclear. We hypothesize that allograft and recipient survivals in offspring-to-parent living donor kidney transplantation differ between men and women due to donor-specific alloimmunization during pregnancy. We retrospectively analyzed long-term allograft and patient survival among men and women who received an offspring living donor kidney com- transplantations. Our analysis demonstrated no significant interaction between recipient sex and donor offspring status. We conclude that nonoffspring living donors should be considered whenever feasible for both men and women with multiple donor options.
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clinical research/practice, epidemiology, gender, graft survival, kidney transplantation/ nephrology, kidney transplantation: living donor, pregnancy short-term outcomes. 11 However, there is limited contemporary evidence evaluating longitudinal allograft and patient survival among maternal recipients of offspring LDKTs. Further, existing data do not thoroughly assess whether these kidneys perform as expected given their high degree of HLA matching and overall quality. Most studies that report on outcomes of LDKTs directly compare the performance of kidneys in female recipients with the performance of kidneys in male recipients. [11] [12] [13] In light of a number of studies demonstrating inferior transplant outcomes in male recipients of LDKTs, [14] [15] [16] it is unclear whether men represent an appropriate control group for comparison of outcomes. The question, therefore, remains whether long-term outcomes meet expectations for female recipients of an offspring kidney.
Recent innovations in LD kidney transplantation and an improving understanding of the immunology of pregnancy prompt reconsideration of the potential risks and long-term benefits associated with offspring-to-parent LD kidney transplantation. First, paired exchange programs are now extremely well established. [17] [18] [19] [20] These programs provide the option of finding an alternative and potentially more desir- 11, 12, 23, 24 In this study, we aimed to determine whether offspring LDKTs were associated with optimal long-term outcomes, especially among female recipients with prior donor-specific alloimmunization during pregnancy. To this end, we compared outcomes of recipients of offspring LDKTs with nonoffspring LDKTs after taking sex, degree of detectable sensitization, and HLA matching into careful consideration. The primary objective of this work was to determine whether offspring-to-parent transplants should be embraced or avoided in kidney transplantation.
| METHODS

| Data source
We performed a retrospective analysis of national registry data col- 
| Subjects
The cohort was restricted to patients who receive a transplant be- 
| Outcomes and covariates
The primary outcomes in the study were acute rejection at 1 year, all-cause allograft failure (a composite of allograft failure and mortality), and all-cause mortality. Death-censored allograft failure and allograft failure with death as a competing risk were also evaluated (see or neither), and cytomegalovirus (CMV) risk status (both recipient and donor negative, recipient positive, or recipient negative with positive donor). All analyses were also adjusted by year of transplantation. To account for dependence among observations within the same transplant center (given center-specific differences in recipient and donor selection), all analyses were clustered by transplant center using a robust sandwich estimator for calculation of the standard error.
| Statistical analyses
Statistical analyses were performed by using STATA version 13.0 (StataCorp LP, College Station, TX) with 2-sided hypothesis testing and P-value of <.05 as the criteria for statistical significance.
Descriptive statistics (median and proportion) were used to describe baseline donor and recipient clinical and demographic characteristics.
Rank-sum test was used to compare continuous variables, and χ 2 test was used to compare categorical and binary variables.
Multivariable logistic regression models were performed to assess the outcome of acute rejection at 1 year. Multivariable Cox proportional hazards models were performed to assess the outcomes of allograft failure and mortality. The Cox models were subsequently stratified by recipient factors that are known to have an important impact on the outcomes, including diabetes, 26 African American race, and age. 27 We generated Kaplan-Meier curves with log rank testing to assess for equality of survival distributions. 28 For the multivariable regressions, we selected variables a priori that were known to be risk factors for the outcomes based on clinical judgment and previously published literature. 29, 30 The proportional hazards assumption was assessed via weighted versions of Kaplan-Meier curves by using statistical testing and graphical displays based on the Schoenfeld and scaled Schoenfeld residuals. 31 
| Handling of covariate missingness
Most covariates included in the multivariate models were <5% incomplete. Donor hypertension was highly missing (>20%) and was omitted; understanding current policies with regard to live kidney donation, 32 we anticipated that donor hypertension would have a very low prevalence among LDs (among those donors in whom it was reported, a diagnosis of hypertension was present in <2%).
We performed complete case analysis to address any other missing data. 33 
| RESULTS
| Recipient and donor characteristics
There were 2767 women who met inclusion criteria for the primary analyses (see Figure 1 ), of whom 1332 were recipients of offspring LDKTs and 1435 were recipients of nonoffspring LDKTs.
Recipients of offspring LDKTs were significantly older (median age 59 vs 49 years, P < .001), more likely to be African American race (28% vs 11%, P < .001), and more likely to be diabetic (40% vs 27%, P < .001) compared with recipients of nonoffspring LDKTs (see Table 1 ). Recipients of offspring kidneys were less likely to be CMV high risk (recipient negative, donor positive) than do recipients of nonoffspring kidneys (7% vs 10%, P < .001); other immunologic characteristics, including ABO compatibility, induction immunosuppression, and calcineurin inhibitor immunosuppression, were similar across the 2 groups. Recipients of offspring kidneys had a similar prevalence of total pretransplantation sensitization events as did recipients of nonoffspring kidneys (23% vs 25%, P = .286) but a significantly lower prevalence of previous kidney transplantation (4% vs 9%, P < .001). While recipients of offspring LDKTs had a higher BMI than recipients of nonoffspring LDKTs, the difference in donor and recipient BMI was the same across the 2 groups (0.5 vs 0.5, P = .897). Offspring donors were significantly younger than nonoffspring donors (median age 34 vs 46 years, P < .001) and were more likely to be male (40% vs 34%, P < .001).
In analyses comparing the 1332 female recipients of offspring LDKTs with the 2245 male recipients of offspring LDKTs (see Table S1 ), the women were closer in age to the men (59 vs 61 years, P < .001), more likely to be African American race (28% vs 16%, P < .001), and less likely to be diabetic (40% vs 50%, P < .001) and had a lower BMI (27.9 vs 28.2 kg/m 2 , P = .007). Male recipients had a significantly greater donor-recipient BMI differential (1.6 vs 0.5 kg/m 2 , P < .001), lower prevalence of sensitization events (23% vs 20%, P = .020), and the same prevalence of previous kidney transplantation (4%) compared with female recipients. Table 2 and Figure 2A ) and mortality (aHR 1.37, 95% CI 1.02-1.86; see Table 2 and Figure 2B ) compared with female recipients of nonoffspring kidneys.
| Multivariable regression models
Multivariable Cox models for death-censored allograft failure and mortality as a competing risk demonstrated a trend toward increased risk among female recipients of offspring kidneys but were underpowered to assess for a significant difference (see Table S2 ). Secondary analyses using a modified, expanded cohort (comparing female recipients of offspring LDKTs with female recipients of nonoffspring LDKTs with a minimum of 3 HLA matches and adjusting for PRA) demonstrated a significantly increased risk of death-censored allograft failure (aHR 1.27, 95% CI 1.04-1.56; see Table S3 ) and allograft failure treating mortality as a competing risk (sub-aHR 1.24, 95% CI 1.01-1.53) among female recipients of offspring LDKTs.
In multivariable Cox proportional hazards models using the primary cohort inclusion criteria (recipient age ≥36, exactly 3 HLA matches,
and maximum PRA 0%) and adjusting for sex instead of restricting to female recipients, recipients of offspring LDKTs had a significantly greater risk of all-cause allograft failure (aHR 1.35, 95% CI 1.08-1.68) and mortality (1.30, 95% CI 1.10-1.54) compared with recipients of nonoffspring LDKTs (see Table 3 ). 
| Stratified analyses
Stratified Cox proportional hazards analyses evaluating all-cause allograft failure and mortality were performed by using the modified Tables 4 and S4 ). 
| DISCUSSION
Adult offspring remain a prevalent source of potential LDs for kidney transplant candidates. 1, 9 Although the use of offspring LDs has diminished in recent years in the United States (see Figure S1 ), these donors may nevertheless represent the optimal choice to maximize long-term benefit in LDKT. However, it is unclear whether these donors are really the best option for women, who may have developed an immunologic memory response to the donor during exposure in prior pregnancy that ultimately threatens graft outcomes. Given that LDKT candidates at many centers have access to alternative donors through the pipeline of paired exchange, we asked whether parents achieve the expected benefits of offspring LDs or should potentially be offered paired exchange as an alternative to optimize long-term outcomes. The primary goal of this study was to determine whether offspring donors perform up to expectations in individuals who have been previously exposed to the donor through the unique route of pregnancy. In this study, we used a series of analytic strategies to compare the observed long-term outcomes of offspring-to-mother LDKTs against the expected outcomes among patient cohorts who were not immunologically exposed to the donor during pregnancy. In our primary analysis, female recipients who received a 3-antigen-matched kidney in the absence of pregnancy immunization against their LDs defined the expected long-term patient and graft survival. We found that the risk of graft loss was significantly higher in women who received an offspring LD kidney (ie, mothers) compared with women who received a nonoffspring kidney. This difference in graft survival expanded over 15 years of follow-up and was greater among recipients of kidneys from older donors (age ≥40 years). Analysis of the modified cohort suggested that the difference in graft survival was not entirely attributable to differences in overall patient survival, as inferior graft survival persisted when we examined death-censored graft survival or when death was treated as a competing risk (Table S3) .
F I G U R E 2
Taken in isolation, these results suggest that pregnancy immunization against the donor is detrimental to long-term graft survival.
However, our analyses of offspring and nonoffspring graft survival in men suggest an alternative interpretation. As noted in Table 3 , all recipients of offspring LDs fared worse than did recipients of nonoffspring donors after adjusting for sex. Moreover, graft and patient survivals were similar between mothers and fathers in both the primary and modified cohorts. Our analyses, therefore, collectively suggest that kidney transplants from offspring LDs do not provide the greatest long-term benefit to their recipients compared with recipients who receive comparably well-matched kidneys. Nonetheless, male recipients had worse overall outcomes than female recipients across multiple sensitivity analyses, which has been demonstrated previously. [14] [15] [16] 34, 35 Although there was no significant interaction between recipient sex and offspring status, these findings suggest that male recipients may not be an ideal control for female recipients and further support that female recipients of offspring LDKTs had worse outcomes than expected compared with more-fitting female controls.
Furthermore, due to important sex-based differences in previous immunologic exposures, 36, 37 immune responses, 38 and other unmeasured risk factors, 34, 39, 40 men broadly make a poor control group when evaluating outcomes of kidney transplantation in women.
T Given the premise of the study, we were surprised to find that recipients of any offspring donor fared worse regardless of the sex of the recipient. We currently speculate that either genetic or shared environmental factors between donor and recipient dictate the inferior outcome of these grafts. This hypothesis is indirectly supported by the findings of other investigators who note higher rates of adverse allograft outcomes among recipients of kidneys from LDs who themselves go on to develop end-stage renal disease. 41 Indirect support for this hypothesis may also be provided from within our data set, given the interaction between older donor age and offspring status, as well. However, while we had hoped that stratification by disease etiology would provide particularly useful insight into the biologic factors that contribute to inferior graft survival of offspring kidneys, we could find no interaction between disease etiology and offspring status. These epidemiologic, observational data, therefore, do not provide a biologic mechanism that explains why graft and patient survivals are inferior among recipients of offspring LDKTs.
Additional insights about the biologic process that diminishes offspring-to-parent outcomes may be gained through the study of paired exchange recipient outcomes, particularly the outcomes of Despite these strengths, our study also has a number of important limitations. As with any retrospective study, the analyses were susceptible to unmeasured confounding. Unmeasured confounders that we identified included previous number of pregnancies, which were not adequately captured in the data set; donor hypertension, which was highly missing; and information on donor-specific antibody and cardiovascular comorbidities. Regarding the absence of previous number of pregnancies in the data set, we attempted to overcome this limitation by carefully controlling for sensitization in multiple other ways, including PRA (with our primary cohort being restricted only to patients with a maximal PRA of 0%), previous transfusion exposure, and prior transplant. We do not suspect that missing donor hypertension status influenced the results meaningfully, given that transplant centers generally have strict guidelines regarding LDKTs from LDs with hypertension and the kidneys that are used tend to have no signs of end organ effects that would influence allograft outcomes. 44 Regrettably, the lack of information on donor-specific antibody in the data set limits our ability to understand the degree to which any immunologic mechanisms contributed to long-term graft loss. Similarly, insufficient data on cardiovascular comorbidities limit our ability to adequately adjust our outcome models. Furthermore, given that the OPTN database is a registry that relies on input from transplant centers and organ procurement organizations, it is prone to the possibility of inaccuracies, which, in a cohort as select as this, could feasibly contribute considerable misinformation bias. Additionally, while we controlled for a multitude of critical confounders and covariates related to the relationship between donor type and recipient outcomes, we were inadequately powered to use more-robust matching techniques to account for such issues as confounding by indication and selection bias.
In conclusion, we report that kidney transplants from offspring LDs appear to underperform transplants from comparably HLAmatched LDs, particularly among female recipients and recipients of kidneys from older donors. Altogether, our data suggest that offspring-to-parent transplantations represent an unfavorable pairing independent of recipient sex or prior immunologic exposure through pregnancy. While the decision to transplant any individual with any particular donor must take into account overall donor access and transplantation urgency, our results encourage the escalating use of paired kidney exchange whenever possible to avoid less-favorable pairings such as offspring-to-parent transplantation while maintaining or improving HLA matching between donors and recipients. While this data sset was unable to delineate the biologic factors that contribute to diminished outcomes in recipients of offspring kidneys, our study nevertheless provides important information that will help guide selection of the optimal LD for patients with multiple donor options. Additional work that helps define the longterm impact of donor relationship on recipient outcome will provide much-needed information to help optimize LD-recipient matching through any available vehicle. 
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